At a glance
- Originator Genaera Corporation
- Class Anti-inflammatories; Benzofurans
- Mechanism of Action Mucin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract disorders
Most Recent Events
- 23 May 2003 Preclinical trials in Respiratory tract disorders in USA (PO)